Petros Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $31.8M | $67.4M | $23.8M |
| FY2022 | $15.7M | $32.4M | $9.4M |
| FY2023 | $21.3M | $33.8M | $13.3M |
| FY2024 | $18.1M | $10.6M | $1.7M |
| FY2025 | $2.3M | $5.2M | $5.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $31.8M | $67.4M | $23.8M |
| FY2022 | $15.7M | $32.4M | $9.4M |
| FY2023 | $21.3M | $33.8M | $13.3M |
| FY2024 | $18.1M | $10.6M | $1.7M |
| FY2025 | $2.3M | $5.2M | $5.1M |